Error: Could not add to watchlist. X
+ Watchlist

Nabriva Therapeutics PLC

NBRV:US
NASDAQ GS
9.84
USD
0.97
10.90%
As of 1:09 PM EDT 9/19/2017
Open
9.75
Day Range
9.17 - 10.58
Volume
5,680,619
Previous Close
8.87
52Wk Range
3.52 - 14.10
1 Yr Return
35.64%
Before it's here, it's on the Bloomberg Terminal.
Learn More
Open
9.75
Day Range
9.17 - 10.58
Volume
5,680,619
Previous Close
8.87
52Wk Range
3.52 - 14.10
1 Yr Return
35.64%
YTD Return
65.05%
Current P/E Ratio (TTM)
-
Earnings per Share (EUR) (TTM)
-18.01
Market Cap (m USD)
265.575
Shares Outstanding (m)
27.211
Price/Sales (TTM)
2.49
Dividend Indicated Gross Yield
-
Sector
Health Care
% Price Change
-0.82%
% Price Change
-0.34%

Related Videos

There are currently no related videos for this ticker. Please check back later.
Profile
Nabriva Therapeutics plc operates as a clinical-stage biopharmaceutical company. The Company researches and develops intravenous (IV) and oral formulations of lefamulin for the treatment of community-acquired bacterial pneumonia (CABP). Nabriva Therapeutics serves patients in worldwide.
Address
25-28 North Wall Quay
IFSC
Dublin 1
Ireland
Phone
353-1-649-2000
Show More